At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk-study
In Brief
An observational study evaluating Sampling of 15ml blood and Blood-Sampling for Stroke and Transient Ischemic Attack. Completed, enrolled 1,102 participants across 4 sites in 2 countries.
Detailed Summary
Prospective observational multicenter study to evaluate copeptin as a prognostic marker in patients with an acute cerebrovascular event. It includes four groups of patients, mainly depending on type of initial therapy (intra-arterial thrombolysis, intravenous thrombolysis, conservative treatment, TIA). The study takes place at the Emergency and neurological Department of the University of Bern, Switzerland; Department of Neurology, Goethe University of Frankfurt a.M. (Germany). Further participating centers are under discussion
Study Details
Timeline
Interventions
On admission, 2 x 7.5ml blood tubes will be drawn during the first routine blood sampling
On day 1 after intra-arterial thrombolysis, 2 x 7.5ml blood tubes on the following routine blood-sampling will be drawn.